Health CareCompany Update

Pro Medicus (ASX: PME) Signs A$128 Million New York Hospital Deal

Pro Medicus will deploy its full Visage 7 imaging platform across NYC Health + Hospitals under a 10-year, A$128 million transaction-based contract.

PMEPRO MEDICUS LIMITEDHealth Care2 min read

Xinfb
[ASX: PME] PRO MEDICUS LIMITED a wide exterior view of a large New York City public hospital complex, framed with ambulances and

Listen to article

0:00 / 2:35

Pro Medicus has secured a 10-year, A$128 million contract to deploy its Visage 7 medical imaging platform across NYC Health + Hospitals, adding a large, long-duration agreement to the healthcare software provider’s US business.

The contract was signed through Pro Medicus’ wholly owned US subsidiary, Visage Imaging. It covers the full Visage 7 product stack, comprising Visage 7 Viewer, Visage 7 Workflow and Visage 7 Open Archive.

The headline contract value equates to an average of A$12.8 million a year over the term, although Pro Medicus did not provide a revenue recognition schedule. The agreement uses a transaction-based licensing model and carries potential upside, according to the company.

That model is relevant for shareholders because the final commercial contribution may depend on transaction volumes rather than being limited to a fixed annual licence payment. The announcement did not quantify the possible upside or disclose volume assumptions.

Cloud rollout targets late 2027 go-live

The cloud-based platform will be implemented throughout NYC Health + Hospitals as a unified diagnostic imaging system. Visage Imaging will also migrate data from the customer’s legacy picture archiving and communication system, or PACS, archives into Visage 7 Open Archive.

Visage 7 will provide enterprise-wide image distribution integrated with NYC Health + Hospitals’ electronic health record. This gives the contract a broad operational scope spanning image viewing, clinical workflow, archive migration and distribution rather than a single software module.

Planning for the rollout is due to begin immediately. Pro Medicus is targeting go-live in late in the third quarter of calendar 2027, using its existing cloud implementation process. The gap between signing and launch reflects the planning, data migration and system implementation work required before the platform enters service.

The 10-year term gives Pro Medicus a long contractual relationship with the customer, while the transaction-based structure provides scope for revenue above the stated contract value. However, the company did not disclose implementation costs, expected margins or the timing of payments under the agreement.

Pro Medicus provides medical imaging software and services to hospitals, imaging centres and healthcare groups. Its product portfolio includes radiology information systems, PACS, artificial intelligence and electronic health solutions. The company acquired Visage Imaging in 2009 and operates from Melbourne, Berlin and San Diego.

For investors, the central features of the latest award are its A$128 million value, decade-long duration and use of Pro Medicus’ complete cloud-based imaging platform. The next major operational step is the targeted rollout and go-live in late third-quarter 2027.

Latest PRO MEDICUS LIMITED ASX Announcements

View complete PME announcement history